MicroRNA‐497/fibroblast growth factor‐23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end‐stage renal disease patients who underwent continuous ambulatory peritoneal dialysis
2010 ◽
Vol 95
(2)
◽
pp. 578-585
◽
2015 ◽
Vol 30
(suppl_3)
◽
pp. iii207-iii207